Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Artificial Cells, Nanomedicine and Biotechnology

eISSN: 2169-141XpISSN: 2169-1401
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
13.6
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Biotechnology
SNIP
1.19
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    TAYLOR & FRANCIS LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    GBP 2085
  • Publication Time
    20
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 16%
4-6 50%
7-9 19%
>9 16%

Topics Covered

Curcumin
Chitosan
Lung cancer
Irradiation
Breast cancer
Drug delivery
Phagocytosis
Western blot
Methotrexate
Nanomedicine
Oxidative stress
Osteosarcoma
PLGA
Electrospinning
Pseudomonas aeruginosa
Melatonin
Hepatocellular carcinoma
Transmission electron microscopy
Particle size
Cervical cancer

Recently Published Papers

Year-wise Publication

FAQs

Since when has Artificial Cells, Nanomedicine and Biotechnology been publishing? Faqs

The Artificial Cells, Nanomedicine and Biotechnology has been publishing since 2013 till date.

How frequently is the Artificial Cells, Nanomedicine and Biotechnology published? Faqs

Artificial Cells, Nanomedicine and Biotechnology is published Continuous publication.

Who is the publisher of Artificial Cells, Nanomedicine and Biotechnology? Faqs

The publisher of Artificial Cells, Nanomedicine and Biotechnology is TAYLOR & FRANCIS LTD.

How can I view the journal metrics of Artificial Cells, Nanomedicine and Biotechnology on editage? Faqs

For the Artificial Cells, Nanomedicine and Biotechnology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Artificial Cells, Nanomedicine and Biotechnology? Faqs

The eISSN number is 2169-141X and pISSN number is 2169-1401 for Artificial Cells, Nanomedicine and Biotechnology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Curcumin, Chitosan, Lung cancer, Irradiation, Breast cancer, Drug delivery, Phagocytosis, Western blot, Methotrexate, Nanomedicine, Oxidative stress, Osteosarcoma, PLGA, Electrospinning, Pseudomonas aeruginosa, Melatonin, Hepatocellular carcinoma, Transmission electron microscopy, Particle size, Cervical cancer.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.